Avidicure

Seed
avidicure.com Biotech & Healthcare Oegstgeest, The Netherlands Founded 2022 11-50
Total Funding $50M
Latest Round $50M Seed
Last Announced Jun 6, 2025
Investors 6 Backers
Decision Makers 5 Verified

About Avidicure

Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Oegstgeest, The Netherlands
Year Founded 2022
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website avidicure.com
Domain Registered Date Apr 20, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $50,000,000 · Seed

    fundraisingfox.com

  2. Milestone

    Website domain registered

    avidicure.com

  3. Milestone

    Company founded

    Oegstgeest, The Netherlands

Investors & Backers

6
BioGeneration Ventures
BOM
Curie Capital
EQT Life Sciences
Kurma Partners
V-Bio Ventures

Funding History

1 Round
Seed · Jun 6, 2025

Founders & Leadership

5

Arthur Lahr

Chief Executive Officer

Work email & phone locked Unlock →

Dirk Naeyer

Chief Operating Officer

Work email & phone locked Unlock →

Govert Schouten

Founder

Work email & phone locked Unlock →

Oliver Nussbaumer

Senior Vice President

Work email & phone locked Unlock →

Robert Friesen

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts